Skip to content

Optilite IgM Kit NK012.OPT.A

by The Binding Site Group

Optilite IgM Kit NK012.OPT.A is a Class II device made by The Binding Site Group, cleared under FDA 510(k) K191635 on 15 Jul 2019 (1 earlier submission) and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 05051700017565), active as of 23 Oct 2026. 3 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

3 closed

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k) from GUDID NumberK191635 Date15 Jul 2019IssuedStatusActive
United StatesGUDID listing Number05051700017565 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

Across registries

2 registries list this device

  • FDA 510(k) K191635 decided 15 Jul 2019 Active· +1 more in the status table
  • FDA GUDID UDI-DI 05051700017565 listed 24 Sep 2016 Listed

Recalls

3 recalls · FDA

    • Terminated Z-1327-2020 FDA Class II initiated 29 Jul 2019

    There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

    • Terminated Z-0604-2019 FDA Class II initiated 6 Nov 2018

    Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.

    • Terminated Z-0477-2019 FDA Class II initiated 25 Jul 2018

    After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.

Timeline

6 dated events

  1. Cleared FDA 510(k) K082129
  2. Listed FDA GUDID 05051700017565
  3. Recall initiated FDA recalls Z-0477-2019
  4. Recall initiated FDA recalls Z-0604-2019
  5. Cleared FDA 510(k) K191635
  6. Recall initiated FDA recalls Z-1327-2020

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Optilite IgM Kit
Generic name
Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry
Model / reference
NK012.OPT.A
Primary DI / UDI-DI
05051700017565
510(k) Number
FDA product code
CFN
GMDN term
Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry
Device class
Class II
Regulation number
866.5510
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry.

Other devices from The Binding Site Group

See all devices from The Binding Site Group →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)